Affimed N.V. Gains 227.85%

Fri, May 16, 2025 at 06:53 PM
Affimed N.V. Gains 227.85%

Affimed N.V. (AFMD:NASDAQ) soared at $0.28, representing a gain of 227.8%. The stock got featured on our News Catalysts scanner on Wed, May 14, 2025 at 08:41 AM in the 'INVESTOR UPDATE' category. From Fri, May 02, 2025, the stock recorded 30.00% Up Days and 27.27% Green Days

About Affimed N.V. (AFMD:NASDAQ)

Affimed NV is a clinical-stage biopharmaceutical company. It is engaged in discovering and developing targeted cancer immunotherapies. Its product candidates are being developed in the field of immuno-oncology to fight tumor cells.

Share
Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
monthly
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.